Proteomics International Laboratories will launch its PromarkerEso oesophageal cancer test globally, backed by a top-tier board of gut and cancer experts. Proteomics International Laboratories will launch its PromarkerEso oesophageal cancer test globally, backed by a top-tier board of gut and cancer experts. Business / Companies Sydney Morning Herald – Latest News
Medical big guns help Proteomics rev up Aussie cancer test rollout
